Researcher, body composition analysis
Appears in 1 story
Active researcher
More than 30 million Americans now take GLP-1 receptor agonist drugs like Ozempic and Wegovy to lose weight. A persistent concern has dogged the medications since their rise: that they burn through muscle along with fat, leaving patients weaker even as they get thinner.
Updated May 30
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
